stock price
Meridian Bioscience Fiscal Q3 Preliminary Revenues Drop 25 Percent
The diagnostics segment was negatively impacted by supply chain issues with reagents causing back orders toward the end of the quarter.
360Dx Index Declines 2 Percent in March, Continuing Downward Slope
Of the 31 companies in the index, 11 firms saw their stock prices increase, while 20 saw their share prices decline.
360Dx Index Declines 4 Percent in February, Ending Streak of Gains
Of the 32 companies in the index, 14 firms saw their stock prices increase, while 18 saw their share prices decline.
Meridian Shares Drop as Much as 15 Percent on FDA Questions About SARS-CoV-2 Test
The firm's stock price has dropped since the announcement that the agency would need additional information and it has paused test shipments.
Meridian Bioscience Preliminary Fiscal 2021 Q1 Revenues Up 94 Percent
Growth was driven by demand in its life science segment, particularly for COVID-19-related products, while the diagnostics segment saw uneven improvement.
Oct 23, 2020
BTIG Initiates Coverage of Progenity With Buy Rating
Sep 11, 2020
Hologic Raises Q4 Revenue Guidance
Sep 11, 2020